NEW HAVEN, Conn. (Legal Newsline) — Delaware Attorney General Matt Denn announced Dec. 15 that he had joined with 19 other state attorneys general in filing a federal lawsuit against Heritage Pharmaceuticals Inc., Auribindo Pharma USA Inc., Citron Pharma LLC, Mayne Pharma (USA) Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc.
The states allege the companies entered into a multitude of illegal conspiracies to restrain trade, inflate and manipulate prices and reduce competition within the United States for the drugs doxycycline hyclate delayed release and glyburide.
The state of Connecticut first looked into the matter in July 2014, attempting to discern the reason for suspicious price increases of certain generic pharmaceuticals. The case turned into an ongoing issue related to a number of generic drugs. According to the new lawsuit, these companies were involved in a well-coordinated and long-running series of conspiracies to fix prices and allocate markets.
Joining Delaware in the lawsuit are Connecticut, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania, Virginia and Washington.
The lawsuit was filed in the U.S. District Court for the District of Connecticut.